# G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy

> **NCT00770172** · PHASE3 · COMPLETED · sponsor: **Centre Francois Baclesse** · enrollment: 140 (estimated)

## Conditions studied

- Chemotherapeutic Agent Toxicity
- Neutropenia
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** filgrastim

## Key facts

- **NCT ID:** NCT00770172
- **Lead sponsor:** Centre Francois Baclesse
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-05
- **Final completion:** —
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2011-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770172, "G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT00770172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*